Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soluble beta-1,3/1,6-glucan in chronic diabetic foot ulcers
2005-005754-50Phase 2Completed
- Sponsor
- Biotec Pharmacon ASA
- Start
- May 2006
- Countries
- 1
01
Overview
A Phase 2 trial of Imprime PGG in diabetic foot ulcer (DFU), diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM), sponsored by Biotec Pharmacon ASA. Started May 2006; status: completed.
02
Drugs
Imprime PGG
03
Conditions
diabetic foot ulcer (DFU)diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-005754-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005754-50.